DeepMed Research

MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES

🇹🇿Tanzania

Country: 🇹🇿Tanzania

Ownership: -

Established: 2007-01-01

Employees: -

Market Cap: -

Website: http://www.muhas.ac.tz

Clinical Trials

Hypofractionation for Prostate Cancer in Africa: A Feasibility Study

Active, not recruiting

Conditions: Prostate Cancer

First Posted Date: 2025-04-30

Last Posted Date: 2025-04-30

Lead Sponsor: Muhimbili University of Health and Allied Sciences

Target Recruit Count: 182

Registration Number: NCT06950307

Locations: 🇳🇬
NSIA-LUTH Cancer Center, Lagos, Nigeria
🇿🇦
Inkosi Albert Luthuli Central Hospital, Durban, South Africa
🇹🇿
Ocean Road Cancer Institute, Dar es Salaam, Tanzania

Integrated Hypertension and Diabetes Mellitus Type II Treatment and Care Among People Living With HIV/AIDS

Completed

Conditions: Diabetes Mellitus
HIV Infections
Hypertension

First Posted Date: 2023-03-27

Last Posted Date: 2023-05-08

Lead Sponsor: Muhimbili University of Health and Allied Sciences

Target Recruit Count: 333

Registration Number: NCT05786703

Locations: 🇹🇿
Temeke Regional Referral Hospital, Dar Es Salaam, Tanzania

Triple Artemisinin-based Combination Therapy for Delaying Drug Resistance Development - a Randomized Clinical Trial

Phase 2

Recruiting

Conditions: Uncomplicated Plasmodium Falciparum Malaria

Interventions: Drug: Artemether-lumefantrine then Artesunate amodiaquine
Drug: Artemether-lumefantrine and Amodiaquine Drug Combination
Drug: Artemether-lumefantrine

First Posted Date: 2023-03-13

Last Posted Date: 2024-12-11

Lead Sponsor: Muhimbili University of Health and Allied Sciences

Target Recruit Count: 384

Registration Number: NCT05764746

Locations: 🇹🇿
Kibindu, Bagamoyo, Dar esSalaam, Tanzania
🇹🇿
Yombo Dispensary, Bagamoyo, Yombo, Tanzania

The Effect of Aspirin on HIV Disease Progression Among HIV- Infected Individuals Initiating Anti- Retroviral Therapy

Phase 2

Suspended

Conditions: Cardiovascular Diseases
Hiv

Interventions: Drug: aspirin enteric coated tablet 75 mg

First Posted Date: 2022-09-01

Last Posted Date: 2022-09-01

Lead Sponsor: Muhimbili University of Health and Allied Sciences

Target Recruit Count: 454

Registration Number: NCT05525156

Locations: 🇹🇿
Mwananyamala Regional Referral Hospital, Mbagala Rangi Tatu Hospital, Dar Es Salaam, Tanzania

Entrepreneurship and Beekeeping in Tanzania

Completed

Conditions: Violence, Physical

Interventions: Behavioral: Training sessions

First Posted Date: 2020-10-26

Last Posted Date: 2020-11-17

Lead Sponsor: Muhimbili University of Health and Allied Sciences

Target Recruit Count: 57

Registration Number: NCT04602416

Locations: 🇹🇿
Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania

Effect of Adiposity and Associated Local Microbial Factors on Healing and Progression of Diabetic Foot Ulcers

Recruiting

Conditions: Diabetic Foot Ulcer

Interventions: Other: Normal standard care

First Posted Date: 2019-05-23

Last Posted Date: 2022-12-29

Lead Sponsor: Muhimbili University of Health and Allied Sciences

Target Recruit Count: 300

Registration Number: NCT03960255

Locations: 🇹🇿
Abbas Medical Center, Dar es Salam, Tanzania
🇹🇿
Muhimbili Academic Medical Center, Dar es Salam, Tanzania
🇹🇿
Temeke regional hospital, Dar es Salam, Tanzania

and more 1 locations

"Prolonging the Therapeutic Life Span of Artemisinin-based Combination Therapies (ACT) in Bagamoyo District, Tanzania"

Phase 4

Completed

Conditions: Malaria,Falciparum

Interventions: Drug: Artemether-Lumefantrine Tab 20-120mg
Other: Placebo
Drug: Primaquine Phosphate 0.25 mg/kg

First Posted Date: 2017-08-08

Last Posted Date: 2018-03-27

Lead Sponsor: Muhimbili University of Health and Allied Sciences

Target Recruit Count: 280

Registration Number: NCT03241901

Locations: 🇹🇿
Fukayosi Dispensary, Bagamoyo, Pwani, Tanzania
🇹🇿
Yombo Dispensary, Bagamoyo, Yombo, Tanzania

Mobile-Directly Observed Therapy on Adherence to Hydroxyurea

Phase 2

Completed

Conditions: Sickle Cell Anaemia

Interventions: Drug: Hydroxyurea
Device: Mobile Directly Observed Therapy

First Posted Date: 2016-07-26

Last Posted Date: 2024-06-12

Lead Sponsor: Muhimbili University of Health and Allied Sciences

Target Recruit Count: 98

Registration Number: NCT02844673

Locations: 🇹🇿
Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania

Efficacy and Safety of a Single Low-dose Primaquine for the Clearance of Gametocytes

Phase 4

Completed

Conditions: Plasmodium Falciparum

Interventions: Drug: Primaquine (For artemether-lumefantrine+primaquine arm)
Drug: Placebo (For artemether-lumefantrine arm)

First Posted Date: 2014-03-18

Last Posted Date: 2014-12-08

Lead Sponsor: Muhimbili University of Health and Allied Sciences

Target Recruit Count: 220

Registration Number: NCT02090036

Locations: 🇹🇿
Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania

Parasite Clearance Time and Time to Recurrent Infection Following Treatment With Artemether/Lumefantrine

Phase 4

Completed

Conditions: Instantaneous Clearance

Interventions: Drug: Artemether/lumefantrine

First Posted Date: 2013-11-28

Last Posted Date: 2014-03-18

Lead Sponsor: Muhimbili University of Health and Allied Sciences

Target Recruit Count: 45

Registration Number: NCT01998295

Locations: 🇹🇿
Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy